A reduction in serum levels of IL-6, IL-1β, and TNF-α, rapid recovery of circulating T and B cell frequencies, and increased antibody production against the SARS-CoV-2 spike protein has been reported in severe COVID-19 cases treated with this agent [64]. Here, IL6 is linked to COVID-19.